Phosphatidylserine exposure on the surface of Leishmania amazonensis amastigotes modulates in vivo infection and dendritic cell function

被引:20
作者
Wanderley, J. L. M. [1 ,2 ,3 ]
Thorpe, P. E. [4 ]
Barcinski, M. A. [5 ,6 ]
Soong, L. [3 ,7 ]
机构
[1] Univ Fed Rio de Janeiro, Inst Biomed Sci, Morphol Sci Program, Rio De Janeiro, Brazil
[2] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil
[3] Univ Texas Med Branch, Dept Microbiol & Immunol, Inst Human Infect & Immun, Galveston, TX 77555 USA
[4] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA
[5] Univ Sao Paulo, Dept Parasitol, Inst Biomed Sci, Sao Paulo, Brazil
[6] Inst Oswaldo Cruz, Lab Cellular Biol, Rio De Janeiro, RJ, Brazil
[7] Univ Texas Med Branch, Dept Pathol, Ctr Biodef & Emerging Infect Dis, Sealy Ctr Vaccine Dev, Galveston, TX 77555 USA
关键词
Leishmaniasis; Immune evasion; Leishmania spp; Dendritic cell; CLASS-II MOLECULES; APOPTOTIC CELLS; CUTANEOUS LEISHMANIASIS; T-CELLS; MURINE MACROPHAGES; MEDIATED MACROPINOCYTOSIS; MONOCLONAL-ANTIBODIES; CYTOKINE PRODUCTION; IMMUNE-RESPONSES; VACCINIA VIRUS;
D O I
10.1111/pim.12019
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Leishmania amazonensis parasites can cause diverse forms of leishmaniasis in humans and persistent lesions in most inbred strains of mice. In both cases, the infection is characterized by a marked immunosuppression of the host. We previously showed that amastigote forms of the parasite make use of surface-exposed phosphatidylserine (PS) molecules to infect host cells and promote alternative macrophage activation, leading to uncontrolled intracellular proliferation of the parasites. In this study, we demonstrated that treatment of infected mice with a PS-targeting monoclonal antibody ameliorated parasite loads and lesion development, which correlated with increased proliferative responses by lymphocytes. In addition, we observed an enhanced dendritic cell (DC) activation and antigen presentation in vitro. Our data imply that the recognition of PS exposed on the surface of amastigotes plays a role in down-modulating DC functions, in a matter similar to that of apoptotic cell clearance. This study provides new information regarding the mechanism of immune suppression in Leishmania infection.
引用
收藏
页码:109 / 119
页数:11
相关论文
共 63 条
[1]   TIM-4, a Receptor for Phosphatidylserine, Controls Adaptive Immunity by Regulating the Removal of Antigen-Specific T Cells [J].
Albacker, Lee A. ;
Karisola, Piia ;
Chang, Ya-Jen ;
Umetsu, Sarah E. ;
Zhou, Meixia ;
Akbari, Omid ;
Kobayashi, Norimoto ;
Baumgarth, Nicole ;
Freeman, Gordon J. ;
Umetsu, Dale T. ;
DeKruyff, Rosemarie H. .
JOURNAL OF IMMUNOLOGY, 2010, 185 (11) :6839-6849
[2]   Opinion - Death-defying immunity: do apoptotic cells influence antigen processing and presentation? [J].
Albert, ML .
NATURE REVIEWS IMMUNOLOGY, 2004, 4 (03) :223-231
[3]   Dendritic cells acquire antigen from apoptotic cells and induce class I restricted CTLs [J].
Albert, ML ;
Sauter, B ;
Bhardwaj, N .
NATURE, 1998, 392 (6671) :86-89
[4]  
Antoine JC, 1999, J CELL SCI, V112, P2559
[5]   LOCALIZATION OF MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II MOLECULES IN PHAGOLYSOSOMES OF MURINE MACROPHAGES INFECTED WITH LEISHMANIA-AMAZONENSIS [J].
ANTOINE, JC ;
JOUANNE, C ;
LANG, T ;
PRINA, E ;
DECHASTELLIER, C ;
FREHEL, C .
INFECTION AND IMMUNITY, 1991, 59 (03) :764-775
[6]   Apoptotic mimicry by an obligate intracellular parasite downregulates macrophage microbicidal activity [J].
Balanco, JMD ;
Moreira, MEC ;
Bonomo, A ;
Bozza, PT ;
Amarante-Mendes, G ;
Pirmez, C ;
Barcinski, MA .
CURRENT BIOLOGY, 2001, 11 (23) :1870-1873
[7]   Apoptotic cells deliver processed antigen to dendritic cells for cross-presentation [J].
Blachèr, NE ;
Darnell, RB ;
Albert, ML .
PLOS BIOLOGY, 2005, 3 (06) :1070-1078
[8]   Toll-dependent selection of microbial antigens for presentation by dendritic cells [J].
Blander, JM ;
Medzhitov, R .
NATURE, 2006, 440 (7085) :808-812
[9]   Properties of mouse and human IgG receptors and their contribution to disease models [J].
Bruhns, Pierre .
BLOOD, 2012, 119 (24) :5640-5649
[10]  
Buxbaum LU, 2002, EUR J IMMUNOL, V32, P3206, DOI 10.1002/1521-4141(200211)32:11<3206::AID-IMMU3206>3.0.CO